Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2000
02/15/2000US6025305 Process for producing a lubricant base oil having improved oxidative stability
02/15/2000US6025204 Diagnostic method for detection of placental-derived prostate growth factors
02/15/2000US6025203 The use of a knitted fabric that absorbs liquid as liquid spreading layers in a diagnostic test carrier
02/15/2000US6025202 Self-assembled metal colloid monolayers and detection methods therewith
02/15/2000US6025200 Method for remote detection of volatile taggant
02/15/2000US6025197 Secreted salivary zsig32 polypeptides
02/15/2000US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same
02/15/2000US6025191 For diagnosis, immunotherapy, gene therapy and anticarcinogenic agents
02/15/2000US6025189 To determine the efficacy of sterilization cycles; consisting of indicator holders, controllably movable carriage, radiation emitter, fluorescence sensor, and controller
02/15/2000US6025180 Asp1
02/15/2000US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000US6025164 Bacterial antigens and vaccine compositions
02/15/2000US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies
02/15/2000US6025157 Neurturin receptor
02/15/2000US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections
02/15/2000US6025151 Administering compounds to treat a non-swine subject for elevated platelet derived growth factor levels, jun kinase, c-jun or inflammatory cytokines, or activation of nf-kappab or nf-kappab p65 or neutrophil infiltration
02/15/2000US6025149 Cheaper, noninvasive quantitative analysis of urine sample from pregnant woman in second or third trimester for human chorionic gonadotrophin level, comparing to standards; increased or decreased level indicates risk
02/15/2000US6025148 Specifically reactive with the alpha e subunit; for diagnostic information relating to atherogenesis and/or thrombogenesis and pregnancy status or outcome
02/15/2000US6025146 By crystallizing human macrophage-colony stimulating factor homo- or heterodimer which may have mutations, irradiating to produce a diffraction pattern, and determining three-dimensional structure including receptor-binding region
02/15/2000US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine
02/15/2000US6025144 Immunoassay test kit for measuring bone resorption
02/15/2000US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics
02/15/2000US6025142 Hydrophobic u-PAR binding site
02/15/2000US6025141 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
02/15/2000US6025138 Method for detecting the presence of a polynucleotide encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells
02/15/2000US6025136 Methods and apparatus for DNA sequencing and DNA identification
02/15/2000US6025128 Prediction of prostate cancer progression by analysis of selected predictive parameters
02/15/2000US6025125 Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers
02/15/2000US6024965 Immunology for treatment of aids and t-cell epitopes
02/15/2000US6024936 Antibody-based method of localizing activated thrombin receptors
02/15/2000US6024924 Sampling air flow with trace compounds through sampling cells, connecting semiconductors to chemoreceptors for signals and detection
02/15/2000US6024922 Method of controlling an oxygen analyzer of the Hersch galvanic type
02/15/2000US6024883 Testing disk for handling and carrying samples and method for analyzing, storing, displaying and printing data from blood typing and other related procedures
02/15/2000US6024710 Blood collection tube closure for use with a needle holder
02/15/2000US6024698 Apparatus for monitoring functional characteristics of an organ intended for transplantations
02/15/2000US6024688 Angiostatin fragments and method of use
02/15/2000US6023985 Controller for an environmental test chamber
02/15/2000US6023962 Reservoir-slit rheometer for the viscosity measurement of fast-reacting polymers
02/15/2000US6023961 Micro-viscosity sensor and lubrication analysis system employing the same
02/15/2000CA2189941C Fluorescence polarization detection of nucleic acids
02/15/2000CA2182857C Gas sensor
02/15/2000CA2132001C Methods of treating cancer using modified c-reactive protein
02/15/2000CA2098549C Two step process for coating of antibodies to a solid phase
02/15/2000CA2093667C Mouse monoclonal antibodies and uses thereof
02/15/2000CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway
02/15/2000CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
02/15/2000CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus
02/15/2000CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
02/13/2000CA2280106A1 Visual blood glucose test strip
02/12/2000CA2248989A1 Novel compounds
02/10/2000WO2000007038A2 Protein fragment complementation assays
02/10/2000WO2000007025A2 Methods for predicting drug response, in particular igf-i
02/10/2000WO2000007024A2 Method of protein analysis
02/10/2000WO2000007023A1 Method for assaying hepatitis c virus
02/10/2000WO2000007021A1 Method for assaying physiologically active component
02/10/2000WO2000007020A1 Electrostatic device and method for immunological detection
02/10/2000WO2000007019A1 Method for preparing water-soluble cross-linked conjugates
02/10/2000WO2000007018A2 Three-hybrid screening method for ligand-protein interactions
02/10/2000WO2000007017A2 Method of high-throughput screening
02/10/2000WO2000007016A1 Diagnostic membrane containing fatty acid sarcosinate surfactant
02/10/2000WO2000007015A1 Immunoassay device
02/10/2000WO2000007014A2 Leptin-mediated gene-induction
02/10/2000WO2000007013A2 Analyte test instrument system including data management system
02/10/2000WO2000007012A1 Method and apparatus for determining anticoagulant therapy factors
02/10/2000WO2000007010A1 Method to predict and/or control the strength properties of a foil-like material
02/10/2000WO2000007009A1 Method for determining the shade stability of lacquers
02/10/2000WO2000007008A1 Detection of pyrogen and other impurities in water
02/10/2000WO2000007007A1 Device and method for cell motility assay
02/10/2000WO2000007005A1 Gas sensor comprising a shield grid electrode for minimizing leakage current influences, and the use thereof
02/10/2000WO2000007004A1 Film responsive to bicarbonate ion
02/10/2000WO2000006980A1 Spectral topography of mammalian matter
02/10/2000WO2000006780A1 Methods and reagents for preserving rna in cell and tissue samples
02/10/2000WO2000006779A1 Reversible inhibiting probes
02/10/2000WO2000006778A1 Wavelength-shifting probes and primers
02/10/2000WO2000006774A1 In situ method of analyzing cells
02/10/2000WO2000006773A1 Method of and composite for fluorescent in situ hybridization
02/10/2000WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene
02/10/2000WO2000006771A2 Nucleic acid labeling compounds
02/10/2000WO2000006770A1 Arrayed biomolecules and their use in sequencing
02/10/2000WO2000006768A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
02/10/2000WO2000006767A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases
02/10/2000WO2000006766A1 Method for identification and isolation of hematopoietic progenitor cells
02/10/2000WO2000006761A1 Method and device for measuring blood coagulation or lysis by viscosity changes
02/10/2000WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
02/10/2000WO2000006744A1 Granulocytic ehrlichia genes and uses thereof
02/10/2000WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
02/10/2000WO2000006737A2 Streptococcus pneumoniae proteins and nucleic acid molecules
02/10/2000WO2000006736A2 Nucleic acids and proteins from group b streptococcus
02/10/2000WO2000006726A2 Delta-related polypeptides
02/10/2000WO2000006722A1 Eukaryotic cell-based gene interaction cloning
02/10/2000WO2000006719A1 Nucleic acids encoding proteins involved in sensory transduction
02/10/2000WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006702A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same
1 ... 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 ... 3937